Loading charts and tools…

US equity markets/AI Value chain/TEM

Tempus AI, Inc.

TEM·NASDAQ·USD

72.15+4.99 (+7.43%)

Regular-session close2026-10-27, 16:00 ET·Definitions

Price history2024-06-14 — 2026-10-23Valid trading days: 592 · Through 2026-10-23 · All expected trading dates since listing are present · History update delayed

Operating history2023-06-30 — 2026-06-307 historical metrics · 13 workpaper periods

Coverage limitations

Daily history updates are delayed. Available history through 2026-10-23 remains visible; a current quote does not establish that daily history has been updated.

Requests to the historical-data source are rate limited, delaying daily-price updates. Existing verified periods are retained; trading days not yet retrieved are not fabricated.

The first price observation reaches the verified listing date. This does not mean that security continuity, every trading day and adjusted prices have all been verified throughout the history.

The first price reaches the verified listing date 2024-06-14. Trading-date coverage and price verification are shown separately below.

Trading dates checked for 2024-06-14 — 2026-10-23: all 592 expected dates are present. Complete dates do not establish independent verification of every price.

Security basis: The current security identity has been checked. Continuity with earlier issuers has not been independently verified; listing-date coverage is shown separately. Historical closes use the provider's split adjustments and exclude dividend distributions. Full-history adjustment factors have not been independently recalculated. Price changes do not represent total returns including dividends.

Original verification records

verified-listing-start-covered

History update reason: source-rate-limited-until 2026-10-28T04:39:08.620Z

The IPO note confirms 2024-06-14 as the first trading day for Class A common stock. The IPO closing date of 6/17 is not used as the start of price history.

View sources and versions ↗

Financial drivers from public filings · single quarter

Compare growth, earnings, cash flow and capital investment for aligned reporting periods to examine company-wide financial drivers. Calculation inputs and original filings remain available.

Coverage and applicability

2023-06-30 — 2026-06-30 · Valid observations: 83. These observations analyze public financial data; they are not a standalone sector research report, score or price target. Company-wide figures do not replace segment, product or contract disclosures.

Days sales outstanding (average balance): Applicable definitions of trade receivables, inventory and purchase costs have not been established for this business. A manufacturing cash-conversion cycle is therefore not applied.
Days inventory outstanding (average balance): Applicable definitions of trade receivables, inventory and purchase costs have not been established for this business. A manufacturing cash-conversion cycle is therefore not applied.
Days payable outstanding (average balance): Applicable definitions of trade receivables, inventory and purchase costs have not been established for this business. A manufacturing cash-conversion cycle is therefore not applied.
Cash conversion cycle (average balances): Applicable definitions of trade receivables, inventory and purchase costs have not been established for this business. A manufacturing cash-conversion cycle is therefore not applied.
Cash purchases of productive assets / revenue: The selected capital-expenditure measure does not represent the broader concept of productive-asset purchases.

Price and operations

Research history

Reproducible calculations from public filings, without inferring segment-level results.

Period end is the end of the operating period. Source-publication mode uses the publication date of the document selected, without asserting that it was the first disclosure. Expand the notes below the chart for definitions and sources.

Research view

Add metrics 3

Available metrics: 7

Financials and cash flow

Revenue growth YoY% · Calculated from disclosures · Quarterly9 valid observations · 2024-06-30 — 2026-06-3021.56%2026-06-30Operating margin% · Calculated from disclosures · Quarterly13 valid observations · 2023-06-30 — 2026-06-30-19.85%2026-06-30Net margin% · Calculated from disclosures · Quarterly13 valid observations · 2023-06-30 — 2026-06-301.48%2026-06-30Operating cash flow / revenue% · Calculated from disclosures · Quarterly12 valid observations · 2023-09-30 — 2026-06-30-1.97%2026-06-30(CFO − cash purchases of PP&E) / revenue% · Calculated from disclosures · Quarterly12 valid observations · 2023-09-30 — 2026-06-30-3.57%2026-06-30Cash purchases of PP&E / revenue% · Calculated from disclosures · Quarterly12 valid observations · 2023-09-30 — 2026-06-301.60%2026-06-30(Net income − operating cash flow) / revenue% · Calculated from disclosures · Quarterly12 valid observations · 2023-09-30 — 2026-06-303.44%2026-06-30

2026-10-23Last value in range

Time rangeTEM Share price

2025-10-23 — 2026-10-23

Methodology and controls

Each panel has its own value axis; dates and the cursor are synchronized. Operating data appear only on their observed dates; other dates are left blank. US daily prices are checked against the verified 1997–2027 trading calendar. A missing expected trading day breaks the line; weekends and recorded exchange holidays do not. Operating data are positioned at the actual period end, which is not necessarily the date of public disclosure. Drag within the chart to zoom and move the range window below to pan. Quarterly values are not filled across other trading days.

Underlying data Operating metrics: 3

Observations in this chart, including unverified periods or dates · original values and source versions retained

Selected operating metrics; records with values and current chart gaps appear first. Unverified dates are excluded from charts.
Reporting period end	Operating margin% · Calculated from disclosures	Net margin% · Calculated from disclosures	(CFO − cash purchases of PP&E) / revenue% · Calculated from disclosures
2026-06-302026-06-30	-19.85% Basis · Calculated from disclosures Source version date: 2026-07-30 View calculation inputs · 4 items Currency USD operatingIncome -75,913,000 Revenue 382,486,000 Input source document 0 role numerator Original XBRL field us-gaap:OperatingIncomeLoss Original unit USD Period start 2026-04-01 Period end 2026-06-30 value -75,913,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 1 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-04-01 Period end 2026-06-30 value 382,486,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 TEM · 10-Q · Filing version 2026-07-30	1.48% Basis · Calculated from disclosures Source version date: 2026-07-30 View calculation inputs · 4 items Currency USD Net income 5,642,000 Revenue 382,486,000 Input source document 0 role numerator Original XBRL field us-gaap:NetIncomeLoss Original unit USD Period start 2026-04-01 Period end 2026-06-30 value 5,642,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 1 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-04-01 Period end 2026-06-30 value 382,486,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 TEM · 10-Q · Filing version 2026-07-30	-3.57% Basis · Calculated from disclosures Source version date: 2026-07-30 View calculation inputs · 5 items Currency USD Operating cash flow -7,525,000 Cash capital expenditure 6,125,000 Revenue 382,486,000 Input source document 0 role numerator Original XBRL field us-gaap:NetCashProvidedByUsedInOperatingActivities Original unit USD Period start 2026-01-01 Period end 2026-06-30 value -80,802,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 1 role numerator Original XBRL field us-gaap:NetCashProvidedByUsedInOperatingActivities Original unit USD Period start 2026-01-01 Period end 2026-03-31 value -73,277,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign -1 sourceIds 0 tem-sec-0001193125-26-206356 2 role numerator Original XBRL field us-gaap:PaymentsToAcquirePropertyPlantAndEquipment Original unit USD Period start 2026-01-01 Period end 2026-06-30 value 14,327,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign -1 sourceIds 0 tem-sec-0001193125-26-326090 3 role numerator Original XBRL field us-gaap:PaymentsToAcquirePropertyPlantAndEquipment Original unit USD Period start 2026-01-01 Period end 2026-03-31 value 8,202,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 4 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-04-01 Period end 2026-06-30 value 382,486,000 Filing date 2026-07-30 form 10-Q accn 0001193125-26-326090 Input sign 1 sourceIds 0 tem-sec-0001193125-26-326090 TEM · 10-Q · Filing version 2026-07-30 TEM · 10-Q · Filing version 2026-05-05
2026-03-312026-03-31	-24.33% Basis · Calculated from disclosures Source version date: 2026-05-05 View calculation inputs · 4 items Currency USD operatingIncome -84,711,000 Revenue 348,116,000 Input source document 0 role numerator Original XBRL field us-gaap:OperatingIncomeLoss Original unit USD Period start 2026-01-01 Period end 2026-03-31 value -84,711,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 1 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-01-01 Period end 2026-03-31 value 348,116,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 TEM · 10-Q · Filing version 2026-05-05	-36.17% Basis · Calculated from disclosures Source version date: 2026-05-05 View calculation inputs · 4 items Currency USD Net income -125,919,000 Revenue 348,116,000 Input source document 0 role numerator Original XBRL field us-gaap:NetIncomeLoss Original unit USD Period start 2026-01-01 Period end 2026-03-31 value -125,919,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 1 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-01-01 Period end 2026-03-31 value 348,116,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 TEM · 10-Q · Filing version 2026-05-05	-23.41% Basis · Calculated from disclosures Source version date: 2026-05-05 View calculation inputs · 5 items Currency USD Operating cash flow -73,277,000 Cash capital expenditure 8,202,000 Revenue 348,116,000 Input source document 0 role numerator Original XBRL field us-gaap:NetCashProvidedByUsedInOperatingActivities Original unit USD Period start 2026-01-01 Period end 2026-03-31 value -73,277,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 1 role numerator Original XBRL field us-gaap:PaymentsToAcquirePropertyPlantAndEquipment Original unit USD Period start 2026-01-01 Period end 2026-03-31 value 8,202,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign -1 sourceIds 0 tem-sec-0001193125-26-206356 2 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2026-01-01 Period end 2026-03-31 value 348,116,000 Filing date 2026-05-05 form 10-Q accn 0001193125-26-206356 Input sign 1 sourceIds 0 tem-sec-0001193125-26-206356 TEM · 10-Q · Filing version 2026-05-05
2025-12-312025-12-31	-16.72% Basis · Calculated from disclosures Source version date: 2026-02-24 View calculation inputs · 4 items Currency USD operatingIncome -61,413,000 Revenue 367,211,000 Input source document 0 role numerator Original XBRL field us-gaap:OperatingIncomeLoss Original unit USD Period start 2025-01-01 Period end 2025-12-31 value -252,872,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 1 role numerator Original XBRL field us-gaap:OperatingIncomeLoss Original unit USD Period start 2025-01-01 Period end 2025-09-30 value -191,459,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 2 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-12-31 value 1,271,789,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 3 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-09-30 value 904,578,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 TEM · 10-K · Filing version 2026-02-24 TEM · 10-Q · Filing version 2025-11-04	-14.75% Basis · Calculated from disclosures Source version date: 2026-02-24 View calculation inputs · 4 items Currency USD Net income -54,166,000 Revenue 367,211,000 Input source document 0 role numerator Original XBRL field us-gaap:NetIncomeLoss Original unit USD Period start 2025-01-01 Period end 2025-12-31 value -245,028,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 1 role numerator Original XBRL field us-gaap:NetIncomeLoss Original unit USD Period start 2025-01-01 Period end 2025-09-30 value -190,862,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 2 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-12-31 value 1,271,789,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 3 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-09-30 value 904,578,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 TEM · 10-K · Filing version 2026-02-24 TEM · 10-Q · Filing version 2025-11-04	-11.31% Basis · Calculated from disclosures Source version date: 2026-02-24 View calculation inputs · 5 items Currency USD Operating cash flow -36,788,000 Cash capital expenditure 4,755,000 Revenue 367,211,000 Input source document 0 role numerator Original XBRL field us-gaap:NetCashProvidedByUsedInOperatingActivities Original unit USD Period start 2025-01-01 Period end 2025-12-31 value -218,090,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 1 role numerator Original XBRL field us-gaap:NetCashProvidedByUsedInOperatingActivities Original unit USD Period start 2025-01-01 Period end 2025-09-30 value -181,302,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 2 role numerator Original XBRL field us-gaap:PaymentsToAcquirePropertyPlantAndEquipment Original unit USD Period start 2025-01-01 Period end 2025-12-31 value 21,049,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign -1 sourceIds 0 tem-sec-0001193125-26-066961 3 role numerator Original XBRL field us-gaap:PaymentsToAcquirePropertyPlantAndEquipment Original unit USD Period start 2025-01-01 Period end 2025-09-30 value 16,294,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign 1 sourceIds 0 tem-sec-0001193125-25-264652 4 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-12-31 value 1,271,789,000 Filing date 2026-02-24 form 10-K accn 0001193125-26-066961 Input sign 1 sourceIds 0 tem-sec-0001193125-26-066961 5 role denominator Original XBRL field us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax Original unit USD Period start 2025-01-01 Period end 2025-09-30 value 904,578,000 Filing date 2025-11-04 form 10-Q accn 0001193125-25-264652 Input sign -1 sourceIds 0 tem-sec-0001193125-25-264652 TEM · 10-K · Filing version 2026-02-24 TEM · 10-Q · Filing version 2025-11-04

Calculations and sources 3 items

Operating margin% · Calculated from disclosures

Calculation basis

Operating income / revenue × 100

Reading guide

Uses reported operating income, not adjusted earnings. Differences in expense classification can still limit comparisons across companies. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Data classification

Calculated from disclosures · %

Supporting sources

TEM · 10-Q · Filing version 2024-08-06 TEM · 10-Q · Filing version 2024-11-04 TEM · 10-K · Filing version 2026-02-24 TEM · 10-Q · Filing version 2025-05-06 TEM · 10-Q · Filing version 2025-08-08 TEM · 10-Q · Filing version 2025-11-04 TEM · 10-Q · Filing version 2026-05-05 TEM · 10-Q · Filing version 2026-07-30

Net margin% · Calculated from disclosures

Calculation basis

Selected net-income concept / revenue × 100

Reading guide

May reflect differences in non-controlling interests, taxes and one-time gains or losses. The specific net-income concept is retained for each observation. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Data classification

Calculated from disclosures · %

Supporting sources

(CFO − cash purchases of PP&E) / revenue% · Calculated from disclosures

Calculation basis

(Operating cash flow − cash purchases of PP&E) / revenue × 100

Reading guide

A free-cash-flow proxy deducting only identified PP&E purchases. It does not deduct acquisitions, capital prepayments, intangible assets or lease principal, and does not establish cash distributable to common shareholders. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Data classification

Calculated from disclosures · %

Supporting sources

Business and research scope

How the business turns into revenue and cash, and what the available evidence can establish.

Company filings ↗

Tempus AI, Inc.. The quote provider classifies its industry as Computer Software: Programming, Data Processing. Structured segment, customer-mix and contract information is not yet available. Company information and original financial documents are provided below; business revenue is not inferred from supply-chain classification.

Company profile and filings

Legal name: Tempus AI, Inc.
Exchange / quote currency: NASDAQ / USD
Reporting currency: USD
Source industry classification: Computer Software: Programming, Data Processing
Financial period end / Source version used: 2026-06-30 / 2026-07-30
Value-chain roles (not revenue shares): Applications and data

Check SEC filings index ↗

Related companies in the value chain

Shared value-chain roles do not establish direct peer status or valuation comparability.

MSFTMicrosoft531.33-0.24%10-27 Close

PLTRPalantir198.73-0.06%10-27 Close

CRWDCrowdStrike Holdings, Inc.268.02+2.36%10-27 Close

CRMSalesforce, Inc.240.89-2.71%10-27 Close

NOWServiceNow, Inc.154.78-2.15%10-27 Close

MARKET DATA

Quote details

Candlesticks, volume and cross-company prices

72.15 +7.43%

2026-07-23 — 2026-10-23Price change over the selected period +46.96%

Daily · Provider split-adjusted prices, excluding dividends · USD · Valid closes: 592 / trading dates: 592Market data source

Compare company

MARKET & FUNDAMENTALS

Quote and valuation methodology

Data timestamps

Trading overview

Previous close: 67.16
Session open: 67.18
Session range: 66.50 – 72.89
Session volume: 5.09 M
20 Average daily volume: 6.38 M
Historical range: 22.89 – 104.32

Valuation and cash

Market cap · USD: 13.00 B
Price / sales · TTM: 9.08
Free cash flow yield: -2.02%

Financial denominator

Revenue · TTM: 1.43 B USD
Period end: 2026-06-30
Source version: 2026-07-30

Quote 2026-10-27Market cap retrieved 2026-10-28Financial period end 2026-06-30

Research archiveNo standalone articles or full reports for this company have been included yet

Public financial and operating analysis is available. Standalone research has not yet been published; exploreOperating data、Financial comparison and SourceSource document。

Financial comparison

Select two specific periods to compare changes in scale, earnings and cash.

Quarter · As of 2026-06-30Source version used 2026-07-30 · Original currency USD

Current periodCompareUSD · Quarter

Current period 2026-04-01 — 2026-06-30Comparison period 2026-01-01 — 2026-03-31

Financial comparison of two defined periods; expand values for source records
Line item	Current period	Comparison period	Amount change	Growth
RevenueRecognized revenue; growth is calculated only when the comparison-period base is positive	382.49 M Raw value 382,486,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗	348.12 M Raw value 348,116,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	+34.37 M	+9.87%
Operating incomeOperating margin -19.85% · Change +4.49 percentage points	-75.91 M Raw value -75,913,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗	-84.71 M Raw value -84,711,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	+8.80 M	—
Net incomeNet margin 1.48% · Change +37.65 percentage points	5.64 M Raw value 5,642,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗	-125.92 M Raw value -125,919,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	+131.56 M	—
Operating cash flowOperating cash flow / revenue -1.97% · Change +19.08 percentage points	-7.53 MDerived by subtraction Raw value -7,525,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2026-01-01 — 2026-06-30 · -80.80 M USD · Source version 2026-07-30 Subtract: 2026-01-01 — 2026-03-31 · -73.28 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗	-73.28 M Raw value -73,277,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	+65.75 M	—
Capital expenditureCapital expenditure / revenue 1.60% · Change -0.75 percentage points	6.13 MDerived by subtraction Raw value 6,125,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2026-01-01 — 2026-06-30 · 14.33 M USD · Source version 2026-07-30 Subtract: 2026-01-01 — 2026-03-31 · 8.20 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗	8.20 M Raw value 8,202,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	-2.08 M	-25.32%

Comparable values unavailable for the two selected periods · Gross profit

Gross profit：Reported value unavailable; Reported value unavailable.

Check filing sources ↗

The change is the current value minus the comparison value; it is not automatically classified as year-over-year or quarter-over-quarter. Select a value to inspect reporting dates, filing versions and reconstruction inputs.

Historical trends and full financials

Comparable-period financial trends

2026-06-30Last value in range

Time rangeRevenue

2023-06-30 — 2026-06-30

Methodology and controls

Series with the same unit and frequency share a value axis. Each column compares observations with matching period boundaries and units. Records that fail those checks remain blank. Drag within the chart to zoom and move the range window below to pan. Quarterly values are not filled across other trading days.

Scroll to see all periods; select a value to open its source →

Quarterly financials, USD. Records without verified periods or units are excluded from comparison columns.
Reporting period end · USD	2023-06-30	2023-09-30	2023-12-31	2024-03-31	2024-06-30	2024-09-30	2024-12-31	2025-03-31	2025-06-30	2025-09-30	2025-12-31	2026-03-31	2026-06-30
Revenue	132.42 M Raw value 132,417,000.00 USD 2023-04-01 — 2023-06-30 · USD · Reported data Original filing ↗	136.06 M Raw value 136,057,000.00 USD 2023-07-01 — 2023-09-30 · USD · Reported data Original filing ↗	147.72 MDerived by subtraction Raw value 147,724,000.00 USD 2023-10-01 — 2023-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2023-01-01 — 2023-12-31 · 531.82 M USD · Source version 2026-02-24 Subtract: 2023-01-01 — 2023-09-30 · 384.10 M USD · Source version 2024-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	145.82 M Raw value 145,820,000.00 USD 2024-01-01 — 2024-03-31 · USD · Reported data Original filing ↗	165.97 M Raw value 165,969,000.00 USD 2024-04-01 — 2024-06-30 · USD · Reported data Original filing ↗	180.93 M Raw value 180,929,000.00 USD 2024-07-01 — 2024-09-30 · USD · Reported data Original filing ↗	200.68 MDerived by subtraction Raw value 200,680,000.00 USD 2024-10-01 — 2024-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2024-01-01 — 2024-12-31 · 693.40 M USD · Source version 2026-02-24 Subtract: 2024-01-01 — 2024-09-30 · 492.72 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	255.74 M Raw value 255,737,000.00 USD 2025-01-01 — 2025-03-31 · USD · Reported data Original filing ↗	314.64 M Raw value 314,635,000.00 USD 2025-04-01 — 2025-06-30 · USD · Reported data Original filing ↗	334.21 M Raw value 334,206,000.00 USD 2025-07-01 — 2025-09-30 · USD · Reported data Original filing ↗	367.21 MDerived by subtraction Raw value 367,211,000.00 USD 2025-10-01 — 2025-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2025-01-01 — 2025-12-31 · 1.27 B USD · Source version 2026-02-24 Subtract: 2025-01-01 — 2025-09-30 · 904.58 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	348.12 M Raw value 348,116,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	382.49 M Raw value 382,486,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗
Gross profit	—	—	—	—	—	—	—	—	—	—	—	—	—
Operating income	-45.14 M Raw value -45,138,000.00 USD 2023-04-01 — 2023-06-30 · USD · Reported data Original filing ↗	-44.79 M Raw value -44,789,000.00 USD 2023-07-01 — 2023-09-30 · USD · Reported data Original filing ↗	-52.30 MDerived by subtraction Raw value -52,295,000.00 USD 2023-10-01 — 2023-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2023-01-01 — 2023-12-31 · -196.08 M USD · Source version 2026-02-24 Subtract: 2023-01-01 — 2023-09-30 · -143.79 M USD · Source version 2024-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-53.27 M Raw value -53,274,000.00 USD 2024-01-01 — 2024-03-31 · USD · Reported data Original filing ↗	-533.49 M Raw value -533,492,000.00 USD 2024-04-01 — 2024-06-30 · USD · Reported data Original filing ↗	-53.62 M Raw value -53,616,000.00 USD 2024-07-01 — 2024-09-30 · USD · Reported data Original filing ↗	-50.70 MDerived by subtraction Raw value -50,700,000.00 USD 2024-10-01 — 2024-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2024-01-01 — 2024-12-31 · -691.08 M USD · Source version 2026-02-24 Subtract: 2024-01-01 — 2024-09-30 · -640.38 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-68.69 M Raw value -68,689,000.00 USD 2025-01-01 — 2025-03-31 · USD · Reported data Original filing ↗	-61.77 M Raw value -61,774,000.00 USD 2025-04-01 — 2025-06-30 · USD · Reported data Original filing ↗	-61.00 M Raw value -60,996,000.00 USD 2025-07-01 — 2025-09-30 · USD · Reported data Original filing ↗	-61.41 MDerived by subtraction Raw value -61,413,000.00 USD 2025-10-01 — 2025-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2025-01-01 — 2025-12-31 · -252.87 M USD · Source version 2026-02-24 Subtract: 2025-01-01 — 2025-09-30 · -191.46 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-84.71 M Raw value -84,711,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	-75.91 M Raw value -75,913,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗
Net income	-55.83 M Raw value -55,832,000.00 USD 2023-04-01 — 2023-06-30 · USD · Reported data Original filing ↗	-53.43 M Raw value -53,426,000.00 USD 2023-07-01 — 2023-09-30 · USD · Reported data Original filing ↗	-50.48 MDerived by subtraction Raw value -50,483,000.00 USD 2023-10-01 — 2023-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2023-01-01 — 2023-12-31 · -214.12 M USD · Source version 2026-02-24 Subtract: 2023-01-01 — 2023-09-30 · -163.64 M USD · Source version 2024-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-64.74 M Raw value -64,743,000.00 USD 2024-01-01 — 2024-03-31 · USD · Reported data Original filing ↗	-552.21 M Raw value -552,212,000.00 USD 2024-04-01 — 2024-06-30 · USD · Reported data Original filing ↗	-75.84 M Raw value -75,840,000.00 USD 2024-07-01 — 2024-09-30 · USD · Reported data Original filing ↗	-13.01 MDerived by subtraction Raw value -13,014,000.00 USD 2024-10-01 — 2024-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2024-01-01 — 2024-12-31 · -705.81 M USD · Source version 2026-02-24 Subtract: 2024-01-01 — 2024-09-30 · -692.80 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-68.04 M Raw value -68,037,000.00 USD 2025-01-01 — 2025-03-31 · USD · Reported data Original filing ↗	-42.84 M Raw value -42,843,000.00 USD 2025-04-01 — 2025-06-30 · USD · Reported data Original filing ↗	-79.98 M Raw value -79,982,000.00 USD 2025-07-01 — 2025-09-30 · USD · Reported data Original filing ↗	-54.17 MDerived by subtraction Raw value -54,166,000.00 USD 2025-10-01 — 2025-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2025-01-01 — 2025-12-31 · -245.03 M USD · Source version 2026-02-24 Subtract: 2025-01-01 — 2025-09-30 · -190.86 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-125.92 M Raw value -125,919,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	5.64 M Raw value 5,642,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reported data Original filing ↗
Operating cash flow	—	-52.99 MDerived by subtraction Raw value -52,985,000.00 USD 2023-07-01 — 2023-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2023-01-01 — 2023-09-30 · -174.07 M USD · Source version 2024-11-04 Subtract: 2023-01-01 — 2023-06-30 · -121.09 M USD · Source version 2024-08-06 Original calculation input 1 ↗Original calculation input 2 ↗	-40.27 MDerived by subtraction Raw value -40,267,000.00 USD 2023-10-01 — 2023-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2023-01-01 — 2023-12-31 · -214.34 M USD · Source version 2026-02-24 Subtract: 2023-01-01 — 2023-09-30 · -174.07 M USD · Source version 2024-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-101.38 M Raw value -101,378,000.00 USD 2024-01-01 — 2024-03-31 · USD · Reported data Original filing ↗	-97.08 MDerived by subtraction Raw value -97,080,000.00 USD 2024-04-01 — 2024-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2024-01-01 — 2024-06-30 · -198.46 M USD · Source version 2025-08-08 Subtract: 2024-01-01 — 2024-03-31 · -101.38 M USD · Source version 2025-05-06 Original calculation input 1 ↗Original calculation input 2 ↗	48.66 MDerived by subtraction Raw value 48,664,000.00 USD 2024-07-01 — 2024-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2024-01-01 — 2024-09-30 · -149.79 M USD · Source version 2025-11-04 Subtract: 2024-01-01 — 2024-06-30 · -198.46 M USD · Source version 2025-08-08 Original calculation input 1 ↗Original calculation input 2 ↗	-39.25 MDerived by subtraction Raw value -39,251,000.00 USD 2024-10-01 — 2024-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2024-01-01 — 2024-12-31 · -189.05 M USD · Source version 2026-02-24 Subtract: 2024-01-01 — 2024-09-30 · -149.79 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-105.62 M Raw value -105,624,000.00 USD 2025-01-01 — 2025-03-31 · USD · Reported data Original filing ↗	44.16 MDerived by subtraction Raw value 44,164,000.00 USD 2025-04-01 — 2025-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2025-01-01 — 2025-06-30 · -61.46 M USD · Source version 2026-07-30 Subtract: 2025-01-01 — 2025-03-31 · -105.62 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗	-119.84 MDerived by subtraction Raw value -119,842,000.00 USD 2025-07-01 — 2025-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2025-01-01 — 2025-09-30 · -181.30 M USD · Source version 2025-11-04 Subtract: 2025-01-01 — 2025-06-30 · -61.46 M USD · Source version 2026-07-30 Original calculation input 1 ↗Original calculation input 2 ↗	-36.79 MDerived by subtraction Raw value -36,788,000.00 USD 2025-10-01 — 2025-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2025-01-01 — 2025-12-31 · -218.09 M USD · Source version 2026-02-24 Subtract: 2025-01-01 — 2025-09-30 · -181.30 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	-73.28 M Raw value -73,277,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	-7.53 MDerived by subtraction Raw value -7,525,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2026-01-01 — 2026-06-30 · -80.80 M USD · Source version 2026-07-30 Subtract: 2026-01-01 — 2026-03-31 · -73.28 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗
Capital expenditure	—	15.99 MDerived by subtraction Raw value 15,993,000.00 USD 2023-07-01 — 2023-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2023-01-01 — 2023-09-30 · 31.90 M USD · Source version 2024-11-04 Subtract: 2023-01-01 — 2023-06-30 · 15.91 M USD · Source version 2024-08-06 Original calculation input 1 ↗Original calculation input 2 ↗	2.71 MDerived by subtraction Raw value 2,709,000.00 USD 2023-10-01 — 2023-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2023-01-01 — 2023-12-31 · 34.61 M USD · Source version 2026-02-24 Subtract: 2023-01-01 — 2023-09-30 · 31.90 M USD · Source version 2024-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	6.11 M Raw value 6,108,000.00 USD 2024-01-01 — 2024-03-31 · USD · Reported data Original filing ↗	8.01 MDerived by subtraction Raw value 8,008,000.00 USD 2024-04-01 — 2024-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2024-01-01 — 2024-06-30 · 14.12 M USD · Source version 2025-08-08 Subtract: 2024-01-01 — 2024-03-31 · 6.11 M USD · Source version 2025-05-06 Original calculation input 1 ↗Original calculation input 2 ↗	0.04 MDerived by subtraction Raw value 43,000.00 USD 2024-07-01 — 2024-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2024-01-01 — 2024-09-30 · 14.16 M USD · Source version 2025-11-04 Subtract: 2024-01-01 — 2024-06-30 · 14.12 M USD · Source version 2025-08-08 Original calculation input 1 ↗Original calculation input 2 ↗	7.96 MDerived by subtraction Raw value 7,962,000.00 USD 2024-10-01 — 2024-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2024-01-01 — 2024-12-31 · 22.12 M USD · Source version 2026-02-24 Subtract: 2024-01-01 — 2024-09-30 · 14.16 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	2.07 M Raw value 2,074,000.00 USD 2025-01-01 — 2025-03-31 · USD · Reported data Original filing ↗	7.51 MDerived by subtraction Raw value 7,514,000.00 USD 2025-04-01 — 2025-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2025-01-01 — 2025-06-30 · 9.59 M USD · Source version 2026-07-30 Subtract: 2025-01-01 — 2025-03-31 · 2.07 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗	6.71 MDerived by subtraction Raw value 6,706,000.00 USD 2025-07-01 — 2025-09-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2025-01-01 — 2025-09-30 · 16.29 M USD · Source version 2025-11-04 Subtract: 2025-01-01 — 2025-06-30 · 9.59 M USD · Source version 2026-07-30 Original calculation input 1 ↗Original calculation input 2 ↗	4.76 MDerived by subtraction Raw value 4,755,000.00 USD 2025-10-01 — 2025-12-31 · USD · Reconstructed from cumulative disclosures Fourth quarter reconstructed: full year − first nine months Add: 2025-01-01 — 2025-12-31 · 21.05 M USD · Source version 2026-02-24 Subtract: 2025-01-01 — 2025-09-30 · 16.29 M USD · Source version 2025-11-04 Original calculation input 1 ↗Original calculation input 2 ↗	8.20 M Raw value 8,202,000.00 USD 2026-01-01 — 2026-03-31 · USD · Reported data Original filing ↗	6.13 MDerived by subtraction Raw value 6,125,000.00 USD 2026-04-01 — 2026-06-30 · USD · Reconstructed from cumulative disclosures Quarter reconstructed: current cumulative value − previous cumulative value Add: 2026-01-01 — 2026-06-30 · 14.33 M USD · Source version 2026-07-30 Subtract: 2026-01-01 — 2026-03-31 · 8.20 M USD · Source version 2026-05-05 Original calculation input 1 ↗Original calculation input 2 ↗

Comparison rules and gaps

Comparison columns require aligned period boundaries, currency and duration. Blank values are not zero; directly reported quarters and cumulative reconstructions are distinguished. A non-positive comparison base is shown as an amount change without a percentage growth rate.

View filing source

Events and disclosure records

Completed events, conditional arrangements and the document versions used are listed separately.

Check original source ↗

2026-09-15Disclosed events

Recursion Pharmaceuticals, Inc. (Nasdaq: RXRX) · Customer

Amendment (2026-09-15) to the 2023-11-03 Tempus Master Agreement: term extended from five to six years (through Nov 2029); Recursion's termination-for-convenience right eliminated; Annual License Fees reset to $14m on each of the 3rd, 4th and 5th anniversaries ($42m committed, replacing up to $84m of discretionary fees over two years), at least $4m of each in cash with the balance in RXRX Class A stock and/or cash; aggregate de-identified records accessible reduced [7]

2026-09-15Disclosed events

Recursion Pharmaceuticals, Inc. (Nasdaq: RXRX) · Supply

RNA Foundation Model License Agreement (2026-09-15): Recursion grants Tempus a non-exclusive, non-sublicensable, non-transferable worldwide licence to its TxFM RNA-sequencing foundation model in oncology (diagnostic, clinical and internal R&D use); two-year term; Tempus pays a non-refundable $12m licence fee in two $6m instalments (on execution and on the first anniversary) and provides access to de-identified pathology records with linked clinical data [8]

2026-07-20Disclosed events

Personalis, Inc. (Nasdaq: PSNL) · Capital and financing

Definitive merger agreement to acquire Personalis, Inc. (Nasdaq: PSNL) at $16.25 per share, implying an enterprise value of $1.5 billion net of Tempus' existing ownership interest; signed July 20, 2026 and not yet closed [1]

2025-12-31Conditional arrangements

Pathos AI, Inc. · Capital and financing

Tempus holds a warrant to purchase 23,456,790 shares of Pathos AI at $0.0125 per share, approximately 15% of Pathos' then-outstanding equity, exercisable within a 10-day window of a 20-year term; still held as of December 31, 2025 [6]

View remaining recorded events (3)

2025-08-22Disclosed events

Paige.AI, Inc. · Capital and financing

Acquisition of Paige.AI, Inc. (digital pathology AI); closed August 22, 2025; total consideration $101.5 million ($3.0m cash and $98.5m stock) [3]

2025-03-11Disclosed events

Deep 6 AI, Inc. · Capital and financing

Acquisition of Deep 6 AI, Inc. (AI clinical trial matching); closed March 11, 2025; total consideration $17.4 million ($4.3m cash and $13.1m stock) [4]

2025-02-03Disclosed events

Ambry Genetics Corporation · Capital and financing

Acquisition of Ambry Genetics Corporation; closed February 3, 2025; total consideration $692.3 million ($394.3m cash and $298.0m stock) [2]

Included financial source versions

2026-07-30
10-Q Original financial filings ↗
This page cites periods ending through 2026-06-30. The same document includes multiple comparison periods.
2026-05-05
10-Q Original financial filings ↗
This page cites periods ending through 2026-03-31. The same document includes multiple comparison periods.
2026-02-24
10-K Original financial filings ↗
This page cites periods ending through 2025-12-31. The same document includes multiple comparison periods.
2025-11-04
10-Q Original financial filings ↗
This page cites periods ending through 2025-09-30. The same document includes multiple comparison periods.
2025-08-08
10-Q Original financial filings ↗
This page cites periods ending through 2024-06-30.
2025-05-06
10-Q Original financial filings ↗
This page cites periods ending through 2024-03-31.

Showing the latest 6 recorded source versions. Find the remaining 3 in Source values in the full financial table.

Industry relationships and operating mechanisms

Trace supply and demand through contract performance, operating metrics and cash attribution.

Company in focus

Direct relationships: 8 · Excluded by current filters: 0

Upstream supply

1 companies

2026-09-151 record

TEM

Tempus AI, Inc.

Operating metrics: 7 ↗

Downstream demand

2 companies

2025-041 record

2026-09-151 record

Capital deployed

5 companies

2026-07-201 record

2025-02-031 record

2025-08-221 record

2025-03-111 record

2025-12-311 record

Capital sources: no records under the current criteria; this does not establish that a business relationship is absent.

Goods and services are arranged from supplier to customer; capital is shown separately. Select a relationship to inspect its evidence and operating mechanism. Second-degree paths do not establish guarantees or certain revenue.

Relationship records

8 records

Status / record date	Recorded amount	Capacity basis	Evidence source
Signed / existing2026-09-15	USD 0.042 billionAmount classification not yet structured	Not structured	A · Original filingCheck public source ↗
Signed / existing2026-09-15	USD 0.012 billionAmount classification not yet structured	Not structured	A · Original filingCheck public source ↗
Signed / existing2026-07-20	USD 1.5 billionAcquisition consideration	Not structured	A · Original filingCheck public source ↗
Option2025-12-31	May subscribe for 23,456,790 shares at $0.0125 per sharePurchase thresholds and equity vesting conditions	Not structured	A · Original filingCheck public source ↗
Signed / existing2025-08-22	USD 0.102 billionAcquisition consideration	Not structured	A · Original filingCheck public source ↗
Signed / existing2025-04	USD 0.2 billionAmount classification not yet structured	Not structured	A · Original filingCheck public source ↗
Signed / existing2025-03-11	USD 0.017 billionAcquisition consideration	Not structured	A · Original filingCheck public source ↗
Signed / existing2025-02-03	USD 0.692 billionAcquisition consideration	Not structured	A · Original filingCheck public source ↗

1–8 / 8 records

Downstream demand · Customer

TEM Recursion Pharmaceuticals, Inc.

Signed / existing2026-09-15A · Original filing

Check public source ↗

What this relationship establishes

Amended the master data licensing agreement dated 2023-11-03

Relationship type: Customer
Recorded as signed or existing; performance progress requires separate verification
Amount basis: USD 0.042 billion Amount classification not yet structured
Annual license fees reset to $14m on each of the third, fourth and fifth anniversaries: $42m of committed payments, replacing up to $84m of optional payments over two years
At least $4 million in cash per installment; the balance may be paid in RXRX Class A shares or cash
A period-by-period schedule of payments and revenue recognition has not been established. The recorded amount is not converted into current-period revenue, cash paid or stock-price impact. The graph's USD field retains its stored value; the original wording determines whether an amount is exact, approximate, a floor or a cap.
Attribution: Applies to this relationship; the original document determines the specific legal entities and attribution.
Concentration: A relationship amount and company denominator with matching periods and definitions are not provided
Relationship counts, capacity and total contract value are not measures of revenue or procurement concentration.

Complete record and source location

A · Original filing

Recursion Pharmaceuticals Form 8-K (filed 2026-09-21, Item 1.01); corroborated by Tempus press release of 2026-09-21

Customer demand and execution

The excerpts below come from this record. Verify signed status separately from actual completion.

The term was extended from five to six years, through November 2029
Removed Recursion's termination-for-convenience right
Annual license fees reset to $14m on each of the third, fourth and fifth anniversaries: $42m of committed payments, replacing up to $84m of optional payments over two years

Inputs still needed to quantify the impact

The relevant business's revenue or purchase amount and the denominator used
Order obligations, pricing and cost pass-through provisions
Execution progress, collection schedule and substitutability

The amount associated with a relationship cannot substitute for the company's revenue, earnings or stock-price impact. Applies to this relationship; the original document determines the specific legal entities and attribution.

How to test the operating mechanism

Analytical framework, not a realized impact

Supply and demand terms
TEM supplies products or services to Recursion Pharmaceuticals, Inc.; a customer list is not an irrevocable order.
Operating process
Verify orders, performance, invoicing and collections; monitor changes in customer demand, product mix and selling prices.
Financial outcomes
Assess whether incremental revenue, costs and gross profit, accounts receivable and operating cash flows are consistent.
Testing price implications
First verify the sustainability of earnings and cash flows, then compare valuations; do not infer share-price upside directly from a partnership announcement.

Cross-check relationship events against subsequent disclosures of company revenue, costs, working capital and cash flows; movements in the same direction alone do not establish causation.

Other records for the same counterparty

Review procurement, customer and capital relationships separately. The same cooperation may appear in multiple records; the amounts are not automatically additive.

Relationship type	Status / date	Evidence source
	Signed / existing2026-09-15	A · Original filing

Operating data to test the relationship

TEM · Company-specific metric definitions and classifications

Metrics test operating processes; an overall change cannot be attributed to a single relationship. Expand the definitions to check calculation methods and their applicable boundaries.

Profit and costs

Can revenue growth translate into earnings attributable to shareholders?

Preserve the distinctions relating to depreciation, stock-based compensation, adjustments and segments. The company's margin cannot be applied as this contract's margin.

Operating metric	Latest value	Definition and boundaries
Operating margin ↗2026-06-30 · Research calculation	-19.85%	Definition and boundaries Operating income / revenue × 100 Uses reported operating income, not adjusted earnings. Differences in expense classification can still limit comparisons across companies. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.
Net margin ↗2026-06-30 · Research calculation	1.48%	Definition and boundaries Selected net-income concept / revenue × 100 May reflect differences in non-controlling interests, taxes and one-time gains or losses. The specific net-income concept is retained for each observation. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.
Operating cash flow / revenue ↗2026-06-30 · Research calculation	-1.97%	Definition and boundaries Operating cash flow / revenue × 100 Shows operating cash inflows and outflows, including working capital and taxes. It is neither a contract collection rate nor cash available for shareholder distribution. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.
(CFO − cash purchases of PP&E) / revenue ↗2026-06-30 · Research calculation	-3.57%	Definition and boundaries (Operating cash flow − cash purchases of PP&E) / revenue × 100 A free-cash-flow proxy deducting only identified PP&E purchases. It does not deduct acquisitions, capital prepayments, intangible assets or lease principal, and does not establish cash distributable to common shareholders. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Show remaining company metrics (3)

Other operating observations

What verifiable information does this metric provide about this relationship?

Use the metric's definition and original inputs. Quantitative attribution to this relationship has not been established.

Operating metric	Latest value	Definition and boundaries
Revenue growth YoY ↗2026-06-30 · Research calculation	21.56%	Definition and boundaries (Current-period revenue / comparable prior-year revenue − 1) × 100 Requires the same concept and currency for equal-length periods one year apart, with positive prior-year revenue. A 53-week versus 52-week year may still differ by one week; no daily adjustment is made. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.
(Net income − operating cash flow) / revenue ↗2026-06-30 · Research calculation	3.44%	Definition and boundaries (Net income − operating cash flow) / revenue × 100 The amount difference divided by revenue. This is not the Sloan accrual ratio or an earnings-manipulation score. A positive value only indicates that earnings exceed operating cash flow for the same period. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Investment and funding needs

How much cash is required for construction and procurement before delivery?

Compare prepayments, cash capital expenditure and commissioning plans. Current-period revenue is not a substitute for a full investment-recovery calculation.

Operating metric	Latest value	Definition and boundaries
Cash purchases of PP&E / revenue ↗2026-06-30 · Research calculation	1.6%	Definition and boundaries Cash purchases of PP&E / revenue × 100 Identified cash purchases of PP&E, excluding non-cash additions. Maintenance and expansion investment are not separated. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.

Related companies in the value chain 12 companies · Applications and data

Related browsing is based on overlapping segments in the current graph. It does not establish direct peers, valuation comparability, or a supply, customer or investment relationship.

MSFTMicrosoftCompany research ↗PLTRPalantirCompany research ↗CRWDCrowdStrike Holdings, Inc.Company research ↗CRMSalesforce, Inc.Company research ↗NOWServiceNow, Inc.Company research ↗SNOWSnowflake Inc.Company research ↗ADBEAdobe Inc.Company research ↗DDOGDatadog, Inc.Company research ↗MDBMongoDB, Inc.Company research ↗INODInnodata Inc.Company research ↗AIC3.ai, Inc.Company research ↗BBAIBigBear.ai, Inc.Company research ↗

Search all operating metrics and calculation methods

Operating metric search

Test relationship hypotheses against actual operating series, with their definitions, periods and calculation methods.

Historical research methodology

Company7 / 7 items

Operating metric	Latest value	Period / classification	Definition and interpretation boundaries	Analysis
Revenue growth YoY	21.56%	2026-06-30Research calculation	(Current-period revenue / comparable prior-year revenue − 1) × 100Requires the same concept and currency for equal-length periods one year apart, with positive prior-year revenue. A 53-week versus 52-week year may still differ by one week; no daily adjustment is made. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
Operating margin	-19.85%	2026-06-30Research calculation	Operating income / revenue × 100Uses reported operating income, not adjusted earnings. Differences in expense classification can still limit comparisons across companies. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
Net margin	1.48%	2026-06-30Research calculation	Selected net-income concept / revenue × 100May reflect differences in non-controlling interests, taxes and one-time gains or losses. The specific net-income concept is retained for each observation. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
Operating cash flow / revenue	-1.97%	2026-06-30Research calculation	Operating cash flow / revenue × 100Shows operating cash inflows and outflows, including working capital and taxes. It is neither a contract collection rate nor cash available for shareholder distribution. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
(CFO − cash purchases of PP&E) / revenue	-3.57%	2026-06-30Research calculation	(Operating cash flow − cash purchases of PP&E) / revenue × 100A free-cash-flow proxy deducting only identified PP&E purchases. It does not deduct acquisitions, capital prepayments, intangible assets or lease principal, and does not establish cash distributable to common shareholders. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
Cash purchases of PP&E / revenue	1.6%	2026-06-30Research calculation	Cash purchases of PP&E / revenue × 100Identified cash purchases of PP&E, excluding non-cash additions. Maintenance and expansion investment are not separated. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗
(Net income − operating cash flow) / revenue	3.44%	2026-06-30Research calculation	(Net income − operating cash flow) / revenue × 100The amount difference divided by revenue. This is not the Sloan accrual ratio or an earnings-manipulation score. A positive value only indicates that earnings exceed operating cash flow for the same period. Uses explicit period boundaries, the reported currency and the selected SEC concept. Cumulative reconstructions retain signed inputs. The filing-version date is not a verified first-disclosure date. Missing values are neither replaced with zero nor interpolated into daily observations.	View full series ↗

Source grades, dates and quantitative definitions

A = original SEC or exchange filings; B = company announcements, IR materials, official websites or established media; C = industry-structure inferences or third-party accounts without an independent primary source

Key relationships were reviewed using public information available through 2026-10-23. Historical relationships have not all been individually reverified. Their original dates are retained; delisted entities remain in the relationship archive but are excluded from market-cap weights. Review coverage through 2026-10-23.

Signed status does not mean that the full amount has been paid or that capacity has been delivered. Assess contract value, period revenue, investment, loans, prepayments and guarantee caps separately; do not sum them as a single exposure. Distinguish total power capacity from critical IT load. Company-level metrics cannot be attributed directly to an individual relationship.

Source facts and operating implications are distinguished, with forecasts and conditional scenarios identified as such. Missing relationships mean that this graph has no record of them. Data version 60aad2cdea0eff4f82e9dafe344d1e57aa2b950269b621d7e5bddfef10520644.

EVIDENCE & SOURCES

Data and calculation basis

Sources and filing versions

Quotes and valuation

2026-10-27, 16:00 ET · Regular-session close. History through 2026-10-23 uses provider split-adjusted prices, excluding dividends. Full-history adjustment factors have not been independently recalculated. MA20 is the arithmetic mean of 20 recorded trading-day closes and does not bridge missing prices or known corporate actions. Price comparisons exclude dividend reinvestment and do not represent total returns. Market cap retrieved on 2026-10-28. Prices refresh daily. Source timestamps and website update times are shown separately.

The current security identity has been checked. Continuity with earlier issuers has not been independently verified; listing-date coverage is shown separately.

Original verification notes

verified-listing-start-covered

The IPO note confirms 2024-06-14 as the first trading day for Class A common stock. The IPO closing date of 6/17 is not used as the start of price history.

Nasdaq Quote source page Price-history source page

Financial statements

Reporting period 2026-06-30; filed 2026-07-30. Financials use the company's reporting periods and currency; unavailable values appear as —. Expand the section below each chart to inspect metric definitions, inputs and original sources.

SEC Company filings Raw financial data · JSON

Business evidence

Based on value-chain records; original operating disclosures are still needed.

Citations: 8 · Documents: 4 · Duplicate documents are grouped; individual source locations are retained

1Personalis Form 8-K, Exhibit 99.1 (joint Tempus/Personalis press release)Value-chain archive

Personalis Form 8-K, Exhibit 99.1 (joint Tempus/Personalis press release) · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

Open source

2Tempus AI Form 10-K (FY2025), Business Combinations noteValue-chain archive · 3 citations

References 2

Tempus AI Form 10-K (FY2025), Business Combinations note · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

References 3

Tempus AI Form 10-K (FY2025), Business Combinations note · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

References 4

Tempus AI Form 10-K (FY2025), Business Combinations note · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

Open source

5Tempus AI Form 10-K (FY2025), Related Parties noteValue-chain archive · 2 citations

References 5

Tempus AI Form 10-K (FY2025), Related Parties note · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

References 6

Tempus AI Form 10-K (FY2025), Related Parties note · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

Open source

7Recursion Pharmaceuticals Form 8-K (filed 2026-09-21, Item 1.01); corroborated by Tempus press release of 2026-09-21Value-chain archive · 2 citations

References 7

Recursion Pharmaceuticals Form 8-K (filed 2026-09-21, Item 1.01); corroborated by Tempus press release of 2026-09-21 · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

References 8

Recursion Pharmaceuticals Form 8-K (filed 2026-09-21, Item 1.01); corroborated by Tempus press release of 2026-09-21 · Document date unverified

Graph source summary; original documents have not been individually rechecked. Event dates and source-publication dates are listed separately.

Open source

Missing evidence

Primary-source coverage of the company’s standalone business analysis and falsification criteria is incomplete.
Company-specific operating KPIs are not yet available; financial ratios do not substitute for evidence about products, orders or capacity.

Unresolved business questions

Which products, customers and revenue categories can be independently verified from primary materials?: Existing relationship records do not represent the entire business; company-level primary evidence for segments, products, customer concentration and key operations remains incomplete.

Relationships: Company announcements, framework intentions and signed agreements are distinguished. Contract amounts do not represent payments already made. Records without sources are flagged separately.
Version: 60aad2cdea0eff4f82e9dafe344d1e57aa2b950269b621d7e5bddfef10520644